Sign In
Buy RHHBY
$51.57
+2.51 (+5.12%)
At Close: Jun 04, 2026
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
02:03pm, Thursday, 11'th Nov 2021
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) REGEN-COV. The casiriv
Roche executive says Alzheimer's drug price will be competitive
06:12am, Wednesday, 10'th Nov 2021
Roche Holding AG, still months away from seeking regulatory approval of its experimental Alzheimer's drug, is already taking aim at rival Biogen Inc's Aduhelm, saying that its medication would be pric
Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose
09:21am, Monday, 08'th Nov 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has announced additional results from a Phase 3 trial, which assessed a single dose of REGEN-COV (1,200 mg administered via 4 subcutaneous injections) t
SCHY: International Dividend ETF Mitigating Risks
05:10am, Monday, 08'th Nov 2021
SCHY: International Dividend ETF Mitigating Risks
Roche chairman sees greater flexibility after Novartis deal - paper
05:00am, Saturday, 06'th Nov 2021
Roche's $20.7 billion move to buy back nearly a third of its voting stock from fellow Swiss drugmaker Novartis will give it more strategic flexibility, Chairman Christoph Franz said in an interview pu
Roche says controlling family won't have to make offer to other shareholders
03:55am, Friday, 05'th Nov 2021
Roche said on Friday that its controlling family will be exempt from having to make an offer to other shareholders after the drugmaker's $20.7 billion deal to buy back Novartis's nearly one third voti
7 European Stocks to Buy to Diversify Your Portfolio
02:35pm, Thursday, 04'th Nov 2021
While exposure to U.S.-based securities continues to be a good idea, you can diversify your opportunities by considering European stocks. The post 7 European Stocks to Buy to Diversify Your Portfolio
Novartis Will Sell Back Its Roche Stake for $21 Billion. Both Stocks Are Rising.
05:32am, Thursday, 04'th Nov 2021
A Roche shareholder since 2001, Novartis expects to report a gain of $14 billion from the stake sale, which disentangles two pharma rivals.
Roche climbs on deal to buy back $21 billion stake held by Novartis
04:06am, Thursday, 04'th Nov 2021
Novartis AG and Roche Holding AG said Thursday that the Swiss pharmaceutical companies have agreed for Novartis to sell its holding of Roche bearer shares to Roche for a total consideration of $20.7 b
Novartis sells its Roche stake to Roche for $20.7 billion
02:37am, Thursday, 04'th Nov 2021
Novartis AG, a shareholder in Roche for more than 20 years, said on Thursday the two Swiss drugmakers had agreed that Roche would buy Novartis's nearly one-third voting stake in its cross-town rival f
The Hanover Insurance Group, Inc. (THG) CEO Jack Roche on Q3 2021 Results - Earnings Call Transcript
04:07pm, Thursday, 28'th Oct 2021
The Hanover Insurance Group, Inc. (THG) CEO Jack Roche on Q3 2021 Results - Earnings Call Transcript
Roche's implant for chronic eye disorder wins FDA approval
04:28pm, Friday, 22'nd Oct 2021
(Reuters) -Swiss drugmaker Roche Holding AG said on Friday the U.S. health regulator approved its eye implant for patients with a chronic disorder causing blurred vision, giving them an alternative to
Are These 2 Companies Next for Short Squeezes?
08:07am, Thursday, 21'st Oct 2021
SmileDirectClub and Accelerate Diagnostics are super cheap right now, with very high short positions. Here's why the shorts might rupture.
Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication (Revised)
03:50am, Thursday, 21'st Oct 2021
Roche (RHHBY) immuno-oncology drug Tecentriq gets FDA approval for yet another indication of lung cancer.
Roche Expects Higher FY21 Sales As Delta Variant Boosts Demand For Diagnostics
03:00pm, Wednesday, 20'th Oct 2021
Roche Holding AG (OTC: RHHBY) raised its 2021 sales forecast after posting an 8% rise in nine-month revenues, driven by demand for COVID-19 tests and the strong performance in the broader business.
